Vaccines in the US Bharatbook added a new report on " Vaccines which gives the information of Vaccines in the US ".

The market for vaccines in the US is all set to experience a major growth in the coming times. The ever rising demand for vaccines is predicted to account for over $15 billion by 2015. Almost 86% of the overall demand generated will be of human vaccines. Both pediatric and adult vaccines will account for almost 75% of human vaccine demand throughout 2015. It is predicted that vaccines for cancer ought to have a major share in marketing as it falls under developmental category. As far as the animal vaccine sector goes, it will be the livestock department that will prevail because of issues such as safety of meat and dairy produces. United States to this date remains vigorously involved in the international trading of vaccinations, hence having a trade surplus of nearly $1.5 billion in 2010. Virtually all licensed vaccines in the US.are produced by just a handful of pharmaceutical companies, i.e. Pfizer, GlaxoSmithKline, Merck, Novartis, Sanofi, amongst others. These companies account for 80% of the worldwide vaccine market. With a limited number of manufacturers and many recommended vaccines produced by only a single company, vaccines are susceptible to large fluctuations in supply and availability. However, covering the past decade, the vaccine market in the US has retained its growth pattern with the consumption level having almost quadrupled. Meanwhile, the largest single purchaser of vaccines in the US remains the government. With the booming human vaccines in the US, it is unfortunate that the animal vaccine market is still struggling to expand. The primary reason for this can be attributed to the lack of public awareness and consumers ignoring the fact that prevention is far better than cure. In this industry scenario, Taiyou Research analyzes the Vaccines Market in the US. The report covers the following: • An overview of the basics of vaccines such as what are vaccines, history of vaccination, types of vaccines, experimental vaccines, immune reaction to vaccines, effectiveness of vaccines, production and excipients in vaccines, and the trends in vaccine development. • An analysis of the market for vaccines in the US. The section analyzes the industry through market statistics, vaccine demand scenario in the US, demand for human vaccines, further segmented by adult and adolescent vaccines, pediatric vaccines, and other human vaccines. We also analyze the demand for animal vaccines in the US, along with the regulatory framework impacting the industry and the trade of vaccines in the US.

• Major vaccine technologies used in the US are analyzed, along with industry trends. • Competition in the industry sets the scenario for an analysis of the major industry players such as GSK, Merck, Sanofi, etc. The major players are analyzed through a company overview, analysis of business segments, major products and services, presence in the vaccines market, and a SWOT analysis. • An industry forecast covers the forecast for human vaccines by segments and animal vaccines, apart from an overall market forecast. Taiyou Research’s report on Vaccines in the US is a comprehensive profile of the industry which covers the various segments and players of the industry. Table of Contents : 1. Executive Summary 2. Vaccines 101 2.1 What are Vaccines? 2.2 History of Vaccination 2.3 Types of Vaccines 2.3.1 Attenuated 2.3.2 Conjugate 2.3.3 Killed 2.3.4 Subunit 2.3.5 Toxoid 2.3.6 Valence 2.4 Experimental Vaccines 2.5 Immune Reaction to Vaccines 2.6 Effectiveness of Vaccines 2.7 Production of Vaccines 2.8 Excipients Present in Vaccines 2.9 Delivery Systems for Vaccines 2.10 Trends in Vaccine Development For more information kindly visit : Related Reports Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a FastChanging Industry Vaccines - Austria

Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: Website: Follow us on twitter:!/BharatBook Market Report, Report, USA, Vaccines, Clinical Trial